The goal of pleurectomy/decortication (P/D) and extrapleural pneumonectomy (EPP) is to remove all pleural mesothelioma cancer growth, relieve symptoms and extend the patient’s life span. Because both surgeries are performed locally in the chest cavity, they work best when the cancer has been found as early as possible and not spread outside of the chest cavity.
If the mesothelioma has advanced to a late stage and is no longer localized, neither procedure may provide significant benefit for the patient. In addition, a patient must be in good overall health to survive and recover from any major chest surgery. Otherwise, it cannot safely be offered even in early-stage cases.
The difference between the two procedures is that EPP carries greater risks and has a larger impact on quality of life. Because this surgery removes an entire lung, it is much more traumatic. Patients who undergo an EPP are more than twice as likely to die during the 30 days after surgery than patients who undergo a P/D. Even after a full recovery, EPP permanently limits the patient’s stamina.
P/D may involve scraping cancer cells off the surface of a lung, but it leaves both lungs intact. Most thoracic surgeons now prefer the P/D procedure for this reason, but they will still perform an EPP if they determine it is the only way to remove as much tumor growth as possible.
Some studies have associated P/D with longer survival times than EPP, but this does not necessarily mean the survival advantage comes from the procedure itself. Rather, patients selected for P/D are usually healthier to begin with than patients who undergo EPP, so it is difficult to make a direct comparison.
The cancer stage and cell type, the patient’s age and the types of adjuvant therapies used all affect survival times much more than the type of surgery performed.
|Pleurectomy/Decortication (P/D)||Extrapleural Pneumonectomy (EPP)|
|Less invasive: Removes the lining of the lung and other nearby tissues, but leaves lung intact||More invasive: Removes the lung and surrounding tissues, reducing patient’s quality of life|
|Lower mortality rate: 1–2% of patients die during or immediately after surgery||Higher mortality rate: 4–5% of patients die during or immediately after surgery|
|Less severe complications: May cause prolonged air leak in chest||More severe complications: May cause abnormal heart rate or arterial blockage|
Source: Annals of Translational Medicine, 2017.
Learn About COVID-19 and Mesothelioma
Get a free recording of the COVID-19 and mesothelioma presentation hosted by the experts at The Mesothelioma Center.Get Yours Now
Deciding Which Surgery Is Right
When choosing between EPP and P/D, the surgeon will consider the patient’s specific medical needs and preferences. Many thoracic surgeons are more comfortable with one procedure than the other, so the patient’s choice of cancer center and mesothelioma specialist may influence the type of surgery they receive.
If the patient is a candidate for surgery, the surgeon will consider the size and location of the tumor. If the tumor is localized to the pleural lining, P/D may suffice, but if the tumor has spread to the lung, EPP may be necessary to remove a greater portion of the tumor.
Mesothelioma specialists can use a variety of imaging scans to try to assess the extent of the cancer’s spread, but in many cases, a surgeon will not make the final judgement call until they have opened the patient’s chest cavity during surgery and seen the extent of the tumor growth directly. A surgeon may begin surgery intending to perform P/D but then realize an EPP would be better, or the other way around.
Choosing between the two procedures is complex, but both surgeries can give the patient a good chance to live longer with pleural mesothelioma.
7 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Batirel, H. (2017, June). Extrapleural pneumonectomy (EPP) vs. pleurectomy decortication (P/D).
Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497106/
Schwartz, R.M. et al. (2017, June). The impact of surgical approach on quality of life for pleural malignant mesothelioma.
Retrieved from: http://atm.amegroups.com/article/view/13976/html
Taioli, E., Wolf, A., and Flores, R. (2015, February). Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma.
Retrieved from: http://www.annalsthoracicsurgery.org/article/S0003-4975(14)01926-2/fulltext
Pacific Meso Center. (2011). Dr. Robert Cameron on Treating Mesothelioma: Debunking the Myths about P/D.
Retrieved from: http://www.phlbi.org/sfor-patients/debunking-the-myths-about-pd/
Luckraz, H. et al. (2010, March). Three decades of experience in the surgical multi-modality management of pleural mesothelioma.
Retrieved from: https://academic.oup.com/ejcts/article-lookup/doi/10.1016/j.ejcts.2009.07.032
Flores, R. et al. (2008, March). Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/18329481
- Mineo, T., Ambrogi, V., and Pompeo, E. (2008). "Surgical Management of Malignant Pleural Mesothelioma." In A. Baldi (Ed.), Mesothelioma from Bench Side to Clinic (pp. 413-434). New York: Nova Science Publishers.
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Share this article
Last Modified April 12, 2020